Journal
VIROLOGY
Volume 556, Issue -, Pages 149-160Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2021.01.008
Keywords
HIV-1; HIV-2; Sulforaphane; xCT; SLC7A11; Restriction; 2-LTR circle; Late reverse transcription; Sulfasalazine; Erastin
Categories
Funding
- NIH [AI140993]
Ask authors/readers for more resources
Human macrophages have intrinsic antiviral defenses against HIV-1 infection, with Nrf2 and xCT playing key roles in inhibiting the virus. xCT function impedes infection immediately prior to 2-LTR circle formation.
Human macrophages are protected by intrinsic antiviral defenses that provide moderate protection against HIV-1 infection. Macrophages that do become infected can serve as long-lived reservoirs, to disseminate HIV-1 to CD4(+) T cells. Infection of macrophages with HIV-1 and HIV-2 is inhibited by constitutive mobilization of antioxidant response master transcription regulator Nrf2. The downstream mediator of this restriction was not identified. Among the tens of genes controlled directly by Nrf2 in macrophages, we found that xCT/SLC7A11, a 12-transmembrane, cystine-glutamate antiporter promotes antiretroviral activity. We show here that depletion of xCT mRNA increases HIV-1 infection. Reconstitution of xCT knock out cells with wild-type xCT but not a transport-deficient mutant restores anti-HIV-1 activity. Pharmacological inhibitors of xCT amino acid transport also increase infection. The block is independent of known restriction factors and acts against HIV-1 and HIV-2. Like the block triggered through Nrf2, xCT function impedes infection immediately before 2-LTR circle formation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available